NURO SYSTEM
Percutaneous Tibial Neuromodulation (PTNM)
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
NURO SYSTEM
Percutaneous Tibial Neuromodulation (PTNM)
Percutaneous Tibial Neuromodulation (PTNM) delivered by the NURO™ System is a safe and effective treatment for overactive bladder (OAB). NURO administers adjustable electrical pulses through a needle to stimulate the afferent fibers of the tibial nerve.1 These pulses are thought to relieve OAB symptoms by modulating communication between the bladder and central nervous system (CNS).
Designed to support your patients and your practice, the NURO system combines proven results with easy management. Stimulation levels can be adjusted mid-session and there is no limit on the number of times therapy can be stopped and restarted, so you can change the level of stimulation if patients request it — even after the session has started. Finishing all 12 weeks of therapy will give your patients the best opportunity to see the results they want.1
Medtronic NURO Percutaneous Tibial Neuromodulation is intended to treat patients with overactive bladder and associated symptoms of urinary urgency, urinary frequency, and urge incontinence.
Designed to meet the needs of your practice, the NURO system delivers therapy to your OAB patients efficiently and cost-effectively. Its portability allows you to administer therapy in different locations. Inventory is simply the inexpensive therapy session kit needed to deliver a therapy session.
Getting started with NURO requires no upfront investment for you or your clinic. Simply contact your Medtronic Representative to get started.
If you received your devices after November 2018, there is no required software. If you received your NURO device before November 2018 and have questions about activating your device, installing software on your PC, or loading therapy sessions onto your device, consult the FAQ to learn more about required software.
Kobashi K, Khandwala S, MacDiarmid S, et al. A Prospective Study to Evaluate Efficacy with the NURO Percutaneous Tibial Neuromodulation System in Drug Naïve Patients with overactive bladder syndrome (OAB). Presented at the American Urological Association 2018 Annual Meeting. Journal of Urology. 2018;199(4) Supplement, Page e987.